Please enable Javascript
Conferences
Expert Interviews
Roundtable
Mesothelioma
Non-Small Cell Lung Cancer
ALK+ NSCLC
EGFR+ NSCLC
EGFR+ NSCLC Learning Lab
Immunotherapy in NSCLC
KRAS+ NSCLC
Small Cell Lung Cancer
Menu
Ticiana Leal, MD
Articles by Ticiana Leal, MD
Guided by Data: Navigating Biopsies, Biomarkers, and Treatment Strategies in NSCLC
Ticiana Leal, MD
Expert Interviews
|
August 13, 2025
In the second segment of this roundtable series, the panel discusses the importance of safe sampling in biomarker testing.
View More
From Screening to Strategy: Navigating the First Steps in Lung Cancer Care
Ticiana Leal, MD
ASCO 2025
|
August 12, 2025
In the first segment of this roundtable series, the panel discusses the initial steps in NSCLC diagnosis and treatment.
View More
Panel Discusses Implications of 5-Year Data From CheckMate 9LA
Millie Das, MD
ASCO 2024
|
August 6, 2024
Experts weigh in on the long-term results presented at the 2024 American Society of Clinical Oncology Annual Meeting.
View More
Experts Discuss Unanswered Questions in NSCLC
Millie Das, MD
ASCO 2024
|
August 6, 2024
The panel discusses key questions about NSCLC treatment regimens and the research that could answer them.
View More
Panel Shares Management Considerations for Patients Undergoing NSCLC Treatment
Millie Das, MD
ASCO 2024
|
August 6, 2024
Experts discuss important management considerations and the importance of working with a multidisciplinary team.
View More
Lung Cancer Clinicians Reflect on Major Updates From American Society of Clinical Oncology Annual Meeting
Millie Das, MD
ASCO 2024
|
August 6, 2024
A panel of experts shares their insights on key developments and advances in lung cancer treatment research.
View More
Panel Discusses How to Talk to Patients About Starting Lung Cancer Treatment
Millie Das, MD
ASCO 2024
|
August 6, 2024
An expert panel discusses treatment and quality-of-life considerations, as well as what to do while awaiting NGS results.
View More
How Do You Choose Among Treatment Regimens for NSCLC?
Millie Das, MD
ASCO 2024
|
August 6, 2024
The panel discusses combination therapies and treatment considerations for patients without targetable mutations.
View More
Experts Reflect on Unmet Needs in Patients With Lung Cancer
Millie Das, MD
ASCO 2024
|
August 6, 2024
Experts weigh in on unmet needs and what clinicians should consider when treating patients who lack driver mutations.
View More
Lung Cancer Screening and Diagnosis: Panelists Share Experiences, Challenges
Millie Das, MD
ASCO 2024
|
August 6, 2024
Experts weigh in on NSCLC screening and diagnostic challenges and the prevalence of metastatic disease at diagnosis.
View More